首页> 外国专利> A TOLEROGENIC DENDRITIC CELL PREPARED BY USING VIRUS FOR TREATING MYOCARDITIS AND A PREPARATION METHOD THEREOF

A TOLEROGENIC DENDRITIC CELL PREPARED BY USING VIRUS FOR TREATING MYOCARDITIS AND A PREPARATION METHOD THEREOF

机译:病毒治疗心肌病的致孔树突状细胞及其制备方法

摘要

PURPOSE: it is a kind of to prepare immunological tolerance Dendritic Cells Dendritic Cells and myocarditis provides to obtain specific immunological tolerance, inhibit the inflammation of myocarditis, effectively treatment myocarditis. ;CONSTITUTION: a kind of the step of preparing dendritic cell vaccination resistance treatment myocarditis includes: the heart in immature dendritic cell culture medium containing TNF-alpha and albumen by Coxsackie virus infection mouse. The protein extract, according to by homogeneous rat heart Coxsackie virus infection and centrifugation. The immature dendritic cell is prepared in dendritic cell precursor culture medium containing GM-CSF (the stimulation granular leukocyte macrophage colony factor) and IL-4. There is the immunological tolerance Dendritic Cells CD86 and CD40 of higher expression quantity to compare immature cell. ;The 2013 of copyright KIPO submissions
机译:目的:它是一种制备免疫耐受性树突状细胞和心肌炎提供的树突状细胞,以获得特定的免疫耐受性,抑制心肌炎的炎症,有效治疗心肌炎。 ;组成:制备树突状细胞疫苗抗性治疗心肌炎的步骤包括:柯萨奇病毒感染小鼠的心脏在含有TNF-α和蛋白的未成熟树突状细胞培养基中。该蛋白质的提取物,是根据受鼠心均质的柯萨奇病毒感染而离心分离的。在含有GM-CSF(刺激性粒状白细胞巨噬细胞集落因子)和IL-4的树突状细胞前体培养基中制备未成熟的树突状细胞。与未成熟细胞相比,有较高表达量的免疫耐受性树突状细胞CD86和CD40。 ; 2013年版权KIPO提交文件

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号